Apex Biotechnology (TPE:1733) Receivables Turnover : 1.41 (As of Mar. 2025)

View and export this data going back to 2001. Start your Free Trial

What is Apex Biotechnology Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Apex Biotechnology's Revenue for the three months ended in Mar. 2025 was NT$559 Mil. Apex Biotechnology's average Accounts Receivable for the three months ended in Mar. 2025 was NT$397 Mil. Hence, Apex Biotechnology's Receivables Turnover for the three months ended in Mar. 2025 was 1.41.

Apex Biotechnology Receivables Turnover Historical Data

The historical data trend for Apex Biotechnology's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apex Biotechnology Receivables Turnover Chart

Apex Biotechnology Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Receivables Turnover

Get a 7-Day Free Trial

5.26

5.33

4.67

4.33

5.83

Apex Biotechnology Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Receivables Turnover	Get a 7-Day Free Trial															1.37	1.19	1.29	1.17	1.41

Competitive Comparison of Apex Biotechnology's Receivables Turnover

For the Biotechnology subindustry, Apex Biotechnology's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apex Biotechnology's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Apex Biotechnology's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Apex Biotechnology's Receivables Turnover falls into.

Save Embed

;

Save Embed

;

Apex Biotechnology Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Apex Biotechnology's Receivables Turnover for the fiscal year that ended in Dec. 2024 is calculated as

	Receivables Turnover (A: Dec. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2024 )	/ (	(Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )
=	1852.211	/ (	(288.39	+	346.636)	/	2 )
=	1852.211	/	317.513
=	5.83

Apex Biotechnology's Receivables Turnover for the quarter that ended in Mar. 2025 is calculated as

	Receivables Turnover (Q: Mar. 2025 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Mar. 2025 )	/ (	(Accounts Receivable (Q: Dec. 2024 )	+	Accounts Receivable (Q: Mar. 2025 ))	/	count )
=	558.753	/ (	(346.636	+	446.928)	/	2 )
=	558.753	/	396.782
=	1.41

Apex Biotechnology (TPE:1733) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Apex Biotechnology Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Apex Biotechnology's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Apex Biotechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apex Biotechnology Corp (TPE:1733) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.7, Li-Hsin 5th Road, Hsinchu Science Park, Hsinchu, TWN, 30078

Website

https://www.apexbio.com

Apex Biotechnology Corp engages mainly in the research, development, production, manufacturing, and selling of biochemical testing instruments and detection strips, and the trade of products and components relevant to the core business. Its products offer Diabetes Care, Home Diagnostics, and Point-of-Care Clinical and Laboratory. Its product offerings include Eclipse plus multipurpose analyzer, Glucosure HT blood glucose monitoring system, and HemoSmart GOLD hemoglobin screening system among others. Company operates in Taiwan, USA, Italy, Austria, China , Others. Majority of revenue is from USA.

Apex Biotechnology Headlines

No Headlines